We are live on ! Find out more

MLNT

Melinta Therapeutics, Inc. Common Stock

MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

37 hedge funds and large institutions have $584K invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New

Increased

Maintained

Reduced

Closed

542% more call options, than puts

Call options by funds: $289K | Put options by funds: $45K

21% less funds holding

Funds holding: 47 → 37 (-10)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

94% less capital invested

Capital invested by funds: $9.43M → $584K (-$8.85M)

Holders

Holders Change

-10

Holders Change %

-21.28%

% of All Funds

0.73%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$289K

Puts

$45K

Net Calls

+$244K

Net Calls Change

+$186K

Top Buyers

1	Citadel Advisors Miami, Florida	+$102K
2	Royal Bank of Canada Toronto, Ontario, Canada	+$98.9K
3	CCM Condor Capital Management Martinsville, New Jersey	+$70.3K
4	OAM Oxford Asset Management Oxford, United Kingdom	+$68.8K
5	Cetera Investment Advisers Schaumburg, Illinois	+$58.6K

Top Sellers

1	Renaissance Technologies New York	-$2.22M
2	Vanguard Group Malvern, Pennsylvania	-$1.69M
3	SC Sculptor Capital New York	-$374K
4	BlackRock New York	-$360K
5	Dimensional Fund Advisors Austin, Texas	-$268K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Stifel Financial St. Louis, Missouri	$142K	-$223	-92	-0%
2	GIM 2 Granahan Investment Management Waltham, Massachusetts	$128K	+$2.62K	+1,082	+0.4%
3	3 Geode Capital Management Boston, Massachusetts	$60K	-$77K	-31,761	-22%
4	4 Dimensional Fund Advisors Austin, Texas	$52K	-$268K	-110,392	-53%
5	5 Citadel Advisors Miami, Florida	$30K	+$102K	+41,984	+283%
6	CCM 6 Condor Capital Management Martinsville, New Jersey	$23K	+$70.3K	+29,000	+207%
7	7 Royal Bank of Canada Toronto, Ontario, Canada	$22K	+$98.9K	+40,793	+9,531%
8	8 Group One Trading Chicago, Illinois	$18K	-$24.6K	-10,132	-23%
9	OAM 9 Oxford Asset Management Oxford, United Kingdom	$15K	+$68.8K	+28,380	New
10	ARTA 10 A.R.T. Advisors New York	$14K	-$24.9K	-10,264	-28%
11	11 Cetera Investment Advisers Schaumburg, Illinois	$12K	+$58.6K	+24,180	New
12	12 New York State Common Retirement Fund Albany, New York	$10K	–	–	–
13	13 BlackRock New York	$9K	-$360K	-148,658	-90%
14	14 Northern Trust Chicago, Illinois	$9K	-$861	-355	-2%
15	IFG 15 Investors Financial Group Plymouth, Minnesota	$9K	+$39.9K	+16,439	New
16	16 D.E. Shaw & Co New York	$8K	+$34.8K	+14,335	New
17	VF 17 Virtu Financial New York	$8K	+$37.2K	+15,331	New
18	18 Morgan Stanley New York	$6K	+$16.8K	+6,940	+200%
19	PAI 19 Palo Alto Investors Palo Alto, California	$5K	–	–	–
20	20 Bank of Montreal Toronto, Ontario, Canada	$3K	-$17.9K	-7,400	-57%
21	21 Bank of America Charlotte, North Carolina	$1K	+$2.59K	+1,069	+198%
22	22 BNP Paribas Financial Markets Paris, France	$22	-$2.63K	-1,084	-96%
23	23 Renaissance Technologies New York	–	-$2.22M	-582,632	Closed
24	24 Vanguard Group Malvern, Pennsylvania	–	-$1.69M	-442,835	Closed
25	SC 25 Sculptor Capital New York	–	-$374K	-98,200	Closed

MLNT Hedge Fund Activity: Q4 2019 in Review

37 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Melinta Therapeutics, Inc. Common Stock (MLNT) for Q4 2019, worth a combined $584K — down 94% from $9.43M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of MLNT and 7 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, adding an estimated $102K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.22M sold.

37 institutional investors held Melinta Therapeutics, Inc. Common Stock (MLNT) as of Q4 2019, down from 47 in Q3 2019.
Funds reported $584K of Melinta Therapeutics, Inc. Common Stock stock for Q4 2019, down 94% quarter-over-quarter.
7 funds opened new Melinta Therapeutics, Inc. Common Stock positions in Q4 2019 and 17 closed out, a net change of -10 holders.
The largest Melinta Therapeutics, Inc. Common Stock buyer in Q4 2019 was Citadel Advisors, an estimated $102K added.
The largest Melinta Therapeutics, Inc. Common Stock seller in Q4 2019 was Renaissance Technologies, an estimated $2.22M sold.

Based on aggregated 13F filings for Q4 2019.

Melinta Therapeutics, Inc. Common Stock MLNT